DRUG AND BIOTECH STOCKS
Stock prices are down, but they outperform broader markets in the quarter
THIRD-QUARTER STOCK PRICEa
CHANGE FROM SECOND-QUARTER
CHANGE FROM 2001
PRICE/
EARNINGS
HIGH
LOW
CLOSE
CLOSE
CLOSE
RATIOb
MAJOR PHARMACEUTICAL COMPANIES
Abbott Laboratories
$43.80
$31.00
$40.40
7.3%
27.5%
20
Baxter International
43.41
30.55
30.55
31.3
43.0
18
Bristol-Myers Squibb
26.17
20.55
23.80
7.4
53.3
13
Eli Lilly
62.15
48.15
55.34
1.9
29.5
23
Johnson & Johnson
56.20
41.85
54.08
3.5
8.5
26
Merck
53.80
39.05
45.71
9.7
22.3
15
Pfizer
34.92
25.92
29.02
17.1
27.2
21
Pharmacia
46.25
31.32
38.88
3.8
8.8
26
Schering-Plough
25.50
20.75
21.32
13.3
40.5
13
Wyeth
49.90
29.75
31.80
37.9
48.2
13
C&EN pharmaceutical indexc (1992 = 100)
394
304
342
10.7%
30.9%
--
Dow Jones industrial average
9380
7592
7592
17.9%
24.2%
--
BIOPHARMACEUTICAL AND DRUG DISCOVERY COMPANIES
Amgen
$48.54
$31.07
$41.70
0.4%
26.1%
32
Biogen
38.95
29.08
29.27
29.4
49.0
17
Celera Genomics
11.38
7.41
7.95
33.8
70.2
def
Cephalon
48.50
36.81
40.82
9.7
46.0
def
Chiron
41.98
27.41
34.94
1.2
20.3
33
Cytogen
1.00
0.40
0.40
62.7
86.7
def
Genentech
36.90
25.50
32.63
2.6
39.9
38
Genzyme
25.34
16.88
20.61
7.1
65.6
20
Gilead Sciences
37.04
26.55
33.53
2.0
49.0
def
Icos
28.96
13.84
20.97
23.8
63.5
def
MedImmune
29.79
20.87
20.87
20.9
55.0
37
Millennium Pharmaceuticals
14.66
8.75
9.32
23.3
62.0
def
Protein Design Labs
13.59
8.30
8.30
23.6
74.7
def
Vertex Pharmaceuticals
23.68
12.95
18.49
13.6
24.8
def
Xoma
6.58
3.38
6.27
57.1
36.4
def
C&EN biopharmaceutical indexd (1992 = 100)
324
229
261
7.4%
44.7%
--
NASDAQe index
1448
1172
1172
20.0%
39.9%
--
a Adjusted for stock splits. b As of Sept. 30. Excludes extraordinary and nonrecurring items. c Based on average stock value for the above-named 10 companies. d Based on average stock value for the above-named 15 companies. e National Association of Securities Dealers Automated Quotations. def = deficit in previous four quarters.
Chemical & Engineering News
Copyright © 2002 American Chemical Society